EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeit

[18F]FB(ePEG12)12-exendin-4 noninvasive imaging of insulinoma negative for insulin immunostaining on specimen from endoscopic ultrasonography-guided fine needle aspiration: a case report with review of literature

Daisuke Otani, Takaaki Murakami, Saeko Murakami, Ikuko Hanaoka, Hiroyuki Fujimoto, Yoichi Shimizu, Kanae Kawai Miyake, Kentaro Sakaki, Yohei Ueda, Daisuke Tanaka, Tsuyoshi Ohno, Hironori Shimizu und 5 weitere

Endocrine Journal · 2024

DOI: 10.1507/endocrj.ej24-0187 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Endocrine Journal, 2024. Verfasst von Daisuke Otani und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan. Hauptthemen laut MEDLINE: Insulinoma, Pancreatic Neoplasms, Endoscopic Ultrasound-Guided Fine Needle Aspiration. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Insulinomas are the most common functional pancreatic neuroendocrine neoplasm; when treatment is delayed, they induce hyperinsulinemic hypoglycemia, which is life-threatening. As surgical resection is the only curative treatment for insulinoma, preoperative localization is crucial; however, localization based on conventional imaging modalities such as computed tomography (CT) and magnetic resonance imaging is often inconclusive. Somatostatin receptor-targeted imaging is another option for detecting pancreatic neuroendocrine neoplasms but has low sensitivity and is not specific for insulinoma. The clinical application of other localizing approaches such as selective arterial calcium stimulation and endoscopic ultrasonography-guided fine needle aspiration (EUS-FNA) is limited by their being invasive and/or technically complex. Moreover, an EUS-FNA specimen of an insulinoma may be negative on insulin immunostaining. Thus, a noninvasive and clinically practical insulinoma-specific diagnostic tool to discriminate insulinomas with high accuracy is anticipated. Glucagon-like peptide-1 receptor (GLP-1R)-targeted imaging has emerged in the effort to fulfill this need. We recently developed the novel fluorine-18-labeled exendin-4-based probe conjugated with polyethylene glycol, [18F]FB(ePEG12)12-exendin-4 (18F-exendin-4) for positron emission tomography (PET) imaging and reported its clinical benefit in a case of insulinoma in the pancreatic tail. We report here a case of insulinoma in the pancreatic head in which an EUS-FNA specimen was negative on insulin immunostaining while precise preoperative localization and conclusive evidence for curative enucleation was provided by 18F-exendin-4 PET/CT (Japan Registry of Clinical Trials; jRCTs051200156).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InsulinomaPancreatic NeoplasmsEndoscopic Ultrasound-Guided Fine Needle AspirationHumansExenatideInsulinFemaleMaleMiddle AgedPositron Emission Tomography Computed Tomography

Stichwörter der Autor:innen

Exendin-4Glucagon-like peptide-1 receptor (GLP-1R)InsulinomaPancreatic β-cell imagingPositron emission tomography (PET)

Substanzen

ExenatideInsulin

Autor:innen und Institutionen

  • Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan.
  • Department of Metabolism and Endocrinology, Kishiwada City Hospital, Kishiwada 596-8501, Japan.
  • Radioisotope Research Center, Agency for Health, Safety and Environment, Kyoto University, Kyoto 606-8501, Japan.
  • Department of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.
  • Department of Surgery, Kishiwada City Hospital, Kishiwada 596-8501, Japan.
  • Department of Pathology, Kishiwada City Hospital, Kishiwada 596-8501, Japan.

Zitieren

APA

Otani, D., Murakami, T., Murakami, S., Hanaoka, I., Fujimoto, H., Shimizu, Y., Kawai Miyake, K., Sakaki, K., Ueda, Y., Tanaka, D., Ohno, T., Shimizu, H., Uyama, N., Iizuka, N., Yabe, D., Nakamoto, Y., & Inagaki, N. (2024). [18F]FB(ePEG12)12-exendin-4 noninvasive imaging of insulinoma negative for insulin immunostaining on specimen from endoscopic ultrasonography-guided fine needle aspiration: a case report with review of literature. Endocrine Journal. https://doi.org/10.1507/endocrj.ej24-0187

Vancouver

Otani D, Murakami T, Murakami S, Hanaoka I, Fujimoto H, Shimizu Y, et al. [18F]FB(ePEG12)12-exendin-4 noninvasive imaging of insulinoma negative for insulin immunostaining on specimen from endoscopic ultrasonography-guided fine needle aspiration: a case report with review of literature. Endocrine Journal. 2024. doi:10.1507/endocrj.ej24-0187

BibTeX
@article{Otani2024,
  author = {Otani, Daisuke and Murakami, Takaaki and Murakami, Saeko and Hanaoka, Ikuko and Fujimoto, Hiroyuki and Shimizu, Yoichi and Kawai Miyake, Kanae and Sakaki, Kentaro and Ueda, Yohei and Tanaka, Daisuke and Ohno, Tsuyoshi and Shimizu, Hironori and Uyama, Naoki and Iizuka, Norishige and Yabe, Daisuke and Nakamoto, Yuji and Inagaki, Nobuya},
  title = {[18F]FB(ePEG12)12-exendin-4 noninvasive imaging of insulinoma negative for insulin immunostaining on specimen from endoscopic ultrasonography-guided fine needle aspiration: a case report with review of literature},
  journal = {Endocrine Journal},
  year = {2024},
  doi = {10.1507/endocrj.ej24-0187}
}
Kostenlos starten →